 | • レポートコード：D0GIR-01335 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、循環腫瘍細胞（CTC）の世界市場を広く調査・分析し、今後の市場展望をまとめております。循環腫瘍細胞（CTC）の種類別市場規模（CTC濃縮、CTC検出、CTC分析）、用途別市場規模（乳がん、前立腺がん、大腸がん、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Menarini-Silicon Biosystems、Advanced Cell Diagnostics、Celsee、Qiagen（Adnagen）、Greiner Bio-one GmbH、Clearbridge Biomedics、Fluxion Biosciences、ApoCell、Fluidigm、Aviva Biosciences、Ikonisys、Biocept、Sysmex Corporation、ANGLE、Vortex BioSciences、CytoTrack、Epic Sciences、ScreenCell、Gilupi、Cynvenio ・地域別グローバル市場分析 2015年-2020年 ・循環腫瘍細胞（CTC）の北米市場（アメリカ、カナダ、メキシコ） ・循環腫瘍細胞（CTC）のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・循環腫瘍細胞（CTC）のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・循環腫瘍細胞（CTC）の南米市場（ブラジル、アルゼンチン） ・循環腫瘍細胞（CTC）の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：CTC濃縮、CTC検出、CTC分析 ・用途別分析：乳がん、前立腺がん、大腸がん、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Circulating Tumor Cell market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.5% in the forecast period of 2020 to 2025 and will expected to reach USD 9859 million by 2025, from USD 6382.4 million in 2019.
The Circulating Tumor Cell market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Circulating Tumor Cell market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Circulating Tumor Cell market has been segmented into:
CTC Enrichment
CTC Detection
CTC Analysis
By Application, Circulating Tumor Cell has been segmented into:
Breast Cancer
Prostate Cancer
Colorectal Cancer
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Circulating Tumor Cell market presented in the report. This section sheds light on the sales growth of different regional and country-level Circulating Tumor Cell markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Circulating Tumor Cell market.
The report offers in-depth assessment of the growth and other aspects of the Circulating Tumor Cell market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Circulating Tumor Cell Market Share Analysis
Circulating Tumor Cell competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Circulating Tumor Cell sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Circulating Tumor Cell sales, revenue and market share for each player covered in this report.
The major players covered in Circulating Tumor Cell are:
Menarini-Silicon Biosystems
Advanced Cell Diagnostics
Celsee
Qiagen（Adnagen）
Greiner Bio-one GmbH
Clearbridge Biomedics
Fluxion Biosciences
ApoCell
Fluidigm
Aviva Biosciences
Ikonisys
Biocept
Sysmex Corporation
ANGLE
Vortex BioSciences
CytoTrack
Epic Sciences
ScreenCell
Gilupi
Cynvenio
Table of Contents
1 Circulating Tumor Cell Market Overview
1.1 Product Overview and Scope of Circulating Tumor Cell
1.2 Classification of Circulating Tumor Cell by Type
1.2.1 Global Circulating Tumor Cell Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Circulating Tumor Cell Revenue Market Share by Type in 2019
1.2.3 CTC Enrichment
1.2.4 CTC Detection
1.2.5 CTC Analysis
1.3 Global Circulating Tumor Cell Market by Application
1.3.1 Overview: Global Circulating Tumor Cell Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Other
1.4 Global Circulating Tumor Cell Market by Regions
1.4.1 Global Circulating Tumor Cell Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Circulating Tumor Cell (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Circulating Tumor Cell Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cell Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cell Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Circulating Tumor Cell Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cell Status and Prospect (2015-2025)
2 Company Profiles
2.1 Menarini-Silicon Biosystems
2.1.1 Menarini-Silicon Biosystems Details
2.1.2 Menarini-Silicon Biosystems Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Menarini-Silicon Biosystems SWOT Analysis
2.1.4 Menarini-Silicon Biosystems Product and Services
2.1.5 Menarini-Silicon Biosystems Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.2 Advanced Cell Diagnostics
2.2.1 Advanced Cell Diagnostics Details
2.2.2 Advanced Cell Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Advanced Cell Diagnostics SWOT Analysis
2.2.4 Advanced Cell Diagnostics Product and Services
2.2.5 Advanced Cell Diagnostics Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.3 Celsee
2.3.1 Celsee Details
2.3.2 Celsee Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Celsee SWOT Analysis
2.3.4 Celsee Product and Services
2.3.5 Celsee Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.4 Qiagen（Adnagen）
2.4.1 Qiagen（Adnagen） Details
2.4.2 Qiagen（Adnagen） Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Qiagen（Adnagen） SWOT Analysis
2.4.4 Qiagen（Adnagen） Product and Services
2.4.5 Qiagen（Adnagen） Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.5 Greiner Bio-one GmbH
2.5.1 Greiner Bio-one GmbH Details
2.5.2 Greiner Bio-one GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Greiner Bio-one GmbH SWOT Analysis
2.5.4 Greiner Bio-one GmbH Product and Services
2.5.5 Greiner Bio-one GmbH Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.6 Clearbridge Biomedics
2.6.1 Clearbridge Biomedics Details
2.6.2 Clearbridge Biomedics Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Clearbridge Biomedics SWOT Analysis
2.6.4 Clearbridge Biomedics Product and Services
2.6.5 Clearbridge Biomedics Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.7 Fluxion Biosciences
2.7.1 Fluxion Biosciences Details
2.7.2 Fluxion Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Fluxion Biosciences SWOT Analysis
2.7.4 Fluxion Biosciences Product and Services
2.7.5 Fluxion Biosciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.8 ApoCell
2.8.1 ApoCell Details
2.8.2 ApoCell Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 ApoCell SWOT Analysis
2.8.4 ApoCell Product and Services
2.8.5 ApoCell Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.9 Fluidigm
2.9.1 Fluidigm Details
2.9.2 Fluidigm Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Fluidigm SWOT Analysis
2.9.4 Fluidigm Product and Services
2.9.5 Fluidigm Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.10 Aviva Biosciences
2.10.1 Aviva Biosciences Details
2.10.2 Aviva Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Aviva Biosciences SWOT Analysis
2.10.4 Aviva Biosciences Product and Services
2.10.5 Aviva Biosciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.11 Ikonisys
2.11.1 Ikonisys Details
2.11.2 Ikonisys Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Ikonisys SWOT Analysis
2.11.4 Ikonisys Product and Services
2.11.5 Ikonisys Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.12 Biocept
2.12.1 Biocept Details
2.12.2 Biocept Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Biocept SWOT Analysis
2.12.4 Biocept Product and Services
2.12.5 Biocept Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sysmex Corporation
2.13.1 Sysmex Corporation Details
2.13.2 Sysmex Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sysmex Corporation SWOT Analysis
2.13.4 Sysmex Corporation Product and Services
2.13.5 Sysmex Corporation Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.14 ANGLE
2.14.1 ANGLE Details
2.14.2 ANGLE Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 ANGLE SWOT Analysis
2.14.4 ANGLE Product and Services
2.14.5 ANGLE Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.15 Vortex BioSciences
2.15.1 Vortex BioSciences Details
2.15.2 Vortex BioSciences Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Vortex BioSciences SWOT Analysis
2.15.4 Vortex BioSciences Product and Services
2.15.5 Vortex BioSciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.16 CytoTrack
2.16.1 CytoTrack Details
2.16.2 CytoTrack Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 CytoTrack SWOT Analysis
2.16.4 CytoTrack Product and Services
2.16.5 CytoTrack Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.17 Epic Sciences
2.17.1 Epic Sciences Details
2.17.2 Epic Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Epic Sciences SWOT Analysis
2.17.4 Epic Sciences Product and Services
2.17.5 Epic Sciences Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.18 ScreenCell
2.18.1 ScreenCell Details
2.18.2 ScreenCell Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 ScreenCell SWOT Analysis
2.18.4 ScreenCell Product and Services
2.18.3 ScreenCell Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.19 Gilupi
2.19.1 Gilupi Details
2.19.2 Gilupi Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Gilupi SWOT Analysis
2.19.4 Gilupi Product and Services
2.19.5 Gilupi Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
2.20 Cynvenio
2.20.1 Cynvenio Details
2.20.2 Cynvenio Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Cynvenio SWOT Analysis
2.20.4 Cynvenio Product and Services
2.20.5 Cynvenio Circulating Tumor Cell Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Circulating Tumor Cell Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Circulating Tumor Cell Players Market Share
3.2.2 Top 10 Circulating Tumor Cell Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Circulating Tumor Cell Revenue and Market Share by Regions
4.2 North America Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
4.3 Europe Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
4.5 South America Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
5 North America Circulating Tumor Cell Revenue by Countries
5.1 North America Circulating Tumor Cell Revenue by Countries (2015-2020)
5.2 USA Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
5.3 Canada Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
5.4 Mexico Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
6 Europe Circulating Tumor Cell Revenue by Countries
6.1 Europe Circulating Tumor Cell Revenue by Countries (2015-2020)
6.2 Germany Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
6.3 UK Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
6.4 France Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
6.5 Russia Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
6.6 Italy Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Circulating Tumor Cell Revenue by Countries
7.1 Asia-Pacific Circulating Tumor Cell Revenue by Countries (2015-2020)
7.2 China Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
7.3 Japan Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
7.4 Korea Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
7.5 India Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
8 South America Circulating Tumor Cell Revenue by Countries
8.1 South America Circulating Tumor Cell Revenue by Countries (2015-2020)
8.2 Brazil Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
8.3 Argentina Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Circulating Tumor Cell by Countries
9.1 Middle East & Africa Circulating Tumor Cell Revenue by Countries (2015-2020)
9.2 Saudi Arabia Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
9.3 UAE Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
9.4 Egypt Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
9.5 South Africa Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Circulating Tumor Cell Revenue and Market Share by Type (2015-2020)
10.2 Global Circulating Tumor Cell Market Forecast by Type (2019-2024)
10.3 CTC Enrichment Revenue Growth Rate (2015-2025)
10.4 CTC Detection Revenue Growth Rate (2015-2025)
10.5 CTC Analysis Revenue Growth Rate (2015-2025)
11 Global Circulating Tumor Cell Market Segment by Application
11.1 Global Circulating Tumor Cell Revenue Market Share by Application (2015-2020)
11.2 Circulating Tumor Cell Market Forecast by Application (2019-2024)
11.3 Breast Cancer Revenue Growth (2015-2020)
11.4 Prostate Cancer Revenue Growth (2015-2020)
11.5 Colorectal Cancer Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Circulating Tumor Cell Market Size Forecast (2021-2025)
12.1 Global Circulating Tumor Cell Market Size Forecast (2021-2025)
12.2 Global Circulating Tumor Cell Market Forecast by Regions (2021-2025)
12.3 North America Circulating Tumor Cell Revenue Market Forecast (2021-2025)
12.4 Europe Circulating Tumor Cell Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Circulating Tumor Cell Revenue Market Forecast (2021-2025)
12.6 South America Circulating Tumor Cell Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Circulating Tumor Cell Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Circulating Tumor Cell Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Circulating Tumor Cell by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Circulating Tumor Cell Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Circulating Tumor Cell Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Menarini-Silicon Biosystems Corporate Information, Location and Competitors
Table 6. Menarini-Silicon Biosystems Circulating Tumor Cell Major Business
Table 7. Menarini-Silicon Biosystems Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 8. Menarini-Silicon Biosystems SWOT Analysis
Table 9. Menarini-Silicon Biosystems Circulating Tumor Cell Product and Solutions
Table 10. Menarini-Silicon Biosystems Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Advanced Cell Diagnostics Corporate Information, Location and Competitors
Table 12. Advanced Cell Diagnostics Circulating Tumor Cell Major Business
Table 13. Advanced Cell Diagnostics Circulating Tumor Cell Total Revenue (USD Million) (2018-2019)
Table 14. Advanced Cell Diagnostics SWOT Analysis
Table 15. Advanced Cell Diagnostics Circulating Tumor Cell Product and Solutions
Table 16. Advanced Cell Diagnostics Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Celsee Corporate Information, Location and Competitors
Table 18. Celsee Circulating Tumor Cell Major Business
Table 19. Celsee Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 20. Celsee SWOT Analysis
Table 21. Celsee Circulating Tumor Cell Product and Solutions
Table 22. Celsee Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Qiagen（Adnagen） Corporate Information, Location and Competitors
Table 24. Qiagen（Adnagen） Circulating Tumor Cell Major Business
Table 25. Qiagen（Adnagen） Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 26. Qiagen（Adnagen） SWOT Analysis
Table 27. Qiagen（Adnagen） Circulating Tumor Cell Product and Solutions
Table 28. Qiagen（Adnagen） Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Greiner Bio-one GmbH Corporate Information, Location and Competitors
Table 30. Greiner Bio-one GmbH Circulating Tumor Cell Major Business
Table 31. Greiner Bio-one GmbH Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 32. Greiner Bio-one GmbH SWOT Analysis
Table 33. Greiner Bio-one GmbH Circulating Tumor Cell Product and Solutions
Table 34. Greiner Bio-one GmbH Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Clearbridge Biomedics Corporate Information, Location and Competitors
Table 36. Clearbridge Biomedics Circulating Tumor Cell Major Business
Table 37. Clearbridge Biomedics Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 38. Clearbridge Biomedics SWOT Analysis
Table 39. Clearbridge Biomedics Circulating Tumor Cell Product and Solutions
Table 40. Clearbridge Biomedics Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Fluxion Biosciences Corporate Information, Location and Competitors
Table 42. Fluxion Biosciences Circulating Tumor Cell Major Business
Table 43. Fluxion Biosciences Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 44. Fluxion Biosciences SWOT Analysis
Table 45. Fluxion Biosciences Circulating Tumor Cell Product and Solutions
Table 46. Fluxion Biosciences Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. ApoCell Corporate Information, Location and Competitors
Table 48. ApoCell Circulating Tumor Cell Major Business
Table 49. ApoCell Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 50. ApoCell SWOT Analysis
Table 51. ApoCell Circulating Tumor Cell Product and Solutions
Table 52. ApoCell Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Fluidigm Corporate Information, Location and Competitors
Table 54. Fluidigm Circulating Tumor Cell Major Business
Table 55. Fluidigm Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 56. Fluidigm SWOT Analysis
Table 57. Fluidigm Circulating Tumor Cell Product and Solutions
Table 58. Fluidigm Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Aviva Biosciences Corporate Information, Location and Competitors
Table 60. Aviva Biosciences Circulating Tumor Cell Major Business
Table 61. Aviva Biosciences Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 62. Aviva Biosciences SWOT Analysis
Table 63. Aviva Biosciences Circulating Tumor Cell Product and Solutions
Table 64. Aviva Biosciences Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Ikonisys Corporate Information, Location and Competitors
Table 66. Ikonisys Circulating Tumor Cell Major Business
Table 67. Ikonisys Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 68. Ikonisys SWOT Analysis
Table 69. Ikonisys Circulating Tumor Cell Product and Solutions
Table 70. Ikonisys Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Biocept Corporate Information, Location and Competitors
Table 72. Biocept Circulating Tumor Cell Major Business
Table 73. Biocept Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 74. Biocept SWOT Analysis
Table 75. Biocept Circulating Tumor Cell Product and Solutions
Table 76. Biocept Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Sysmex Corporation Corporate Information, Location and Competitors
Table 78. Sysmex Corporation Circulating Tumor Cell Major Business
Table 79. Sysmex Corporation Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 80. Sysmex Corporation SWOT Analysis
Table 81. Sysmex Corporation Circulating Tumor Cell Product and Solutions
Table 82. Sysmex Corporation Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. ANGLE Corporate Information, Location and Competitors
Table 84. ANGLE Circulating Tumor Cell Major Business
Table 85. ANGLE Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 86. ANGLE SWOT Analysis
Table 87. ANGLE Circulating Tumor Cell Product and Solutions
Table 88. ANGLE Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Vortex BioSciences Corporate Information, Location and Competitors
Table 90. Vortex BioSciences Circulating Tumor Cell Major Business
Table 91. Vortex BioSciences Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 92. Vortex BioSciences SWOT Analysis
Table 93. Vortex BioSciences Circulating Tumor Cell Product and Solutions
Table 94. Vortex BioSciences Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. CytoTrack Corporate Information, Location and Competitors
Table 96. CytoTrack Circulating Tumor Cell Major Business
Table 97. CytoTrack Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 98. CytoTrack SWOT Analysis
Table 99. CytoTrack Circulating Tumor Cell Product and Solutions
Table 100. CytoTrack Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Epic Sciences Corporate Information, Location and Competitors
Table 102. Epic Sciences Circulating Tumor Cell Major Business
Table 103. Epic Sciences Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 104. Epic Sciences SWOT Analysis
Table 105. Epic Sciences Circulating Tumor Cell Product and Solutions
Table 106. Epic Sciences Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. ScreenCell Circulating Tumor Cell Type and Application
Table 108. ScreenCell Circulating Tumor Cell Major Business
Table 109. ScreenCell Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 110. ScreenCell SWOT Analysis
Table 111. ScreenCell Circulating Tumor Cell Product and Solutions
Table 112. ScreenCell Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Gilupi Corporate Information, Location and Competitors
Table 114. Gilupi Circulating Tumor Cell Major Business
Table 115. Gilupi Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 116. Gilupi SWOT Analysis
Table 117. Gilupi Circulating Tumor Cell Product and Solutions
Table 118. Gilupi Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Cynvenio Corporate Information, Location and Competitors
Table 120. Cynvenio Circulating Tumor Cell Major Business
Table 121. Cynvenio Circulating Tumor Cell Total Revenue (USD Million) (2017-2018)
Table 122. Cynvenio SWOT Analysis
Table 123. Cynvenio Circulating Tumor Cell Product and Solutions
Table 124. Cynvenio Circulating Tumor Cell Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Global Circulating Tumor Cell Revenue (Million USD) by Players (2015-2020)
Table 126. Global Circulating Tumor Cell Revenue Share by Players (2015-2020)
Table 127. Global Circulating Tumor Cell Revenue (Million USD) by Regions (2015-2020)
Table 128. Global Circulating Tumor Cell Revenue Market Share by Regions (2015-2020)
Table 129. North America Circulating Tumor Cell Revenue by Countries (2015-2020)
Table 130. North America Circulating Tumor Cell Revenue Market Share by Countries (2015-2020)
Table 131. Europe Circulating Tumor Cell Revenue (Million USD) by Countries (2015-2020)
Table 132. Asia-Pacific Circulating Tumor Cell Revenue (Million USD) by Countries (2015-2020)
Table 133. South America Circulating Tumor Cell Revenue by Countries (2015-2020)
Table 134. South America Circulating Tumor Cell Revenue Market Share by Countries (2015-2020)
Table 135. Middle East and Africa Circulating Tumor Cell Revenue (Million USD) by Countries (2015-2020)
Table 136. Middle East and Africa Circulating Tumor Cell Revenue Market Share by Countries (2015-2020)
Table 137. Global Circulating Tumor Cell Revenue (Million USD) by Type (2015-2020)
Table 138. Global Circulating Tumor Cell Revenue Share by Type (2015-2020)
Table 139. Global Circulating Tumor Cell Revenue Forecast by Type (2021-2025)
Table 140. Global Circulating Tumor Cell Revenue by Application (2015-2020)
Table 141. Global Circulating Tumor Cell Revenue Share by Application (2015-2020)
Table 142. Global Circulating Tumor Cell Revenue Forecast by Application (2021-2025)
Table 143. Global Circulating Tumor Cell Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Circulating Tumor Cell Picture
Figure 2. Global Circulating Tumor Cell Revenue Market Share by Type in 2019
Figure 3. CTC Enrichment Picture
Figure 4. CTC Detection Picture
Figure 5. CTC Analysis Picture
Figure 6. Circulating Tumor Cell Revenue Market Share by Application in 2019
Figure 7. Breast Cancer Picture
Figure 8. Prostate Cancer Picture
Figure 9. Colorectal Cancer Picture
Figure 10. Other Picture
Figure 11. Global Circulating Tumor Cell Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Circulating Tumor Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Circulating Tumor Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Circulating Tumor Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Circulating Tumor Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Circulating Tumor Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Circulating Tumor Cell Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Circulating Tumor Cell Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Circulating Tumor Cell Revenue Market Share in 2019
Figure 20. Global Top 10 Players Circulating Tumor Cell Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Circulating Tumor Cell Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Circulating Tumor Cell Revenue Market Share by Regions (2015-2020)
Figure 24. Global Circulating Tumor Cell Revenue Market Share by Regions in 2018
Figure 25. North America Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 26. Europe Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 28. South America Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 30. North America Circulating Tumor Cell Revenue Market Share by Countries (2015-2020)
Figure 31. North America Circulating Tumor Cell Revenue Market Share by Countries in 2019
Figure 32. USA Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 33. Canada Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 35. Europe Circulating Tumor Cell Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Circulating Tumor Cell Revenue Market Share by Countries in 2019
Figure 37. Germany Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 38. UK Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 39. France Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 40. Russia Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 41. Italy Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Circulating Tumor Cell Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Circulating Tumor Cell Revenue Market Share by Countries in 2019
Figure 44. China Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 45. Japan Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 46. Korea Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 47. India Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 49. South America Circulating Tumor Cell Revenue Market Share by Countries (2015-2020)
Figure 50. South America Circulating Tumor Cell Revenue Market Share by Countries in 2019
Figure 51. Brazil Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Circulating Tumor Cell Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Circulating Tumor Cell Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 56. UAE Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Circulating Tumor Cell Revenue and Growth Rate (2015-2020)
Figure 59. Global Circulating Tumor Cell Revenue Share by Type (2015-2020)
Figure 60. Global Circulating Tumor Cell Revenue Share by Type in 2019
Figure 61. Global Circulating Tumor Cell Market Share Forecast by Type (2021-2025)
Figure 62. Global CTC Enrichment Revenue Growth Rate (2015-2020)
Figure 63. Global CTC Detection Revenue Growth Rate (2015-2020)
Figure 64. Global CTC Analysis Revenue Growth Rate (2015-2020)
Figure 65. Global Circulating Tumor Cell Revenue Share by Application (2015-2020)
Figure 66. Global Circulating Tumor Cell Revenue Share by Application in 2019
Figure 67. Global Circulating Tumor Cell Market Share Forecast by Application (2021-2025)
Figure 68. Global Breast Cancer Revenue Growth Rate (2015-2020)
Figure 69. Global Prostate Cancer Revenue Growth Rate (2015-2020)
Figure 70. Global Colorectal Cancer Revenue Growth Rate (2015-2020)
Figure 71. Global Other Revenue Growth Rate (2015-2020)
Figure 72. Global Circulating Tumor Cell Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Circulating Tumor Cell Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Circulating Tumor Cell Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Circulating Tumor Cell Revenue Market Forecast (2021-2025)
Figure 76. Europe Circulating Tumor Cell Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Circulating Tumor Cell Revenue Market Forecast (2021-2025)
Figure 78. South America Circulating Tumor Cell Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Circulating Tumor Cell Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
単一細胞ゲノミクスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Single Cell Genomics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Single Cell Genomics mar…- 腫瘍治療フィールド（TTFields）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Tumor Treating Fields (TTFields) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tumor Treati…
- 交流電場腫瘍治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Alternating Electric Field Tumor Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Al…
- GMP腫瘍壊死因子アルファの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The GMP Tumor Necrosis Factor Alpha market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 希少バイオマーカー検体収集 ・安定化の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rare Biomarkers Specimen Collection And Stabilization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pl…